Lin Gu

925 total citations
48 papers, 725 citations indexed

About

Lin Gu is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Lin Gu has authored 48 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 20 papers in Hepatology and 12 papers in Molecular Biology. Recurrent topics in Lin Gu's work include Hepatitis B Virus Studies (19 papers), Hepatitis C virus research (19 papers) and Liver Disease Diagnosis and Treatment (10 papers). Lin Gu is often cited by papers focused on Hepatitis B Virus Studies (19 papers), Hepatitis C virus research (19 papers) and Liver Disease Diagnosis and Treatment (10 papers). Lin Gu collaborates with scholars based in China, United Kingdom and United States. Lin Gu's co-authors include Yuehua Huang, Lubiao Chen, Yingli Shi, Jie Chen, Yurong Gu, Liang Zhou, Xiaoyan Shi, Xirong Guo, Yifan Lian and Xishan Hao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Virology and Scientific Reports.

In The Last Decade

Lin Gu

47 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Gu China 16 274 202 196 160 148 48 725
Yoko Aoyagi Japan 19 309 1.1× 333 1.6× 103 0.5× 229 1.4× 292 2.0× 59 1.0k
Wanhua Ren China 15 169 0.6× 150 0.7× 120 0.6× 104 0.7× 56 0.4× 43 579
Ngai Na Co Hong Kong 15 791 2.9× 211 1.0× 450 2.3× 100 0.6× 76 0.5× 20 1.2k
Qiuhong Liu China 12 249 0.9× 129 0.6× 105 0.5× 41 0.3× 94 0.6× 37 562
Xiaohui Tian China 11 241 0.9× 83 0.4× 202 1.0× 60 0.4× 97 0.7× 23 479
Elham Hassen Tunisia 16 308 1.1× 208 1.0× 153 0.8× 105 0.7× 121 0.8× 33 745
Sallouha Gabbouj Tunisia 18 349 1.3× 163 0.8× 184 0.9× 105 0.7× 132 0.9× 36 793
Yan Tang China 14 167 0.6× 96 0.5× 75 0.4× 63 0.4× 311 2.1× 25 642
Gordon Stamp United Kingdom 13 174 0.6× 179 0.9× 85 0.4× 21 0.1× 57 0.4× 24 727

Countries citing papers authored by Lin Gu

Since Specialization
Citations

This map shows the geographic impact of Lin Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Gu more than expected).

Fields of papers citing papers by Lin Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Gu. The network helps show where Lin Gu may publish in the future.

Co-authorship network of co-authors of Lin Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Gu. A scholar is included among the top collaborators of Lin Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Gu. Lin Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Xinlei, Shuang Qu, Yunfei Wu, et al.. (2025). Monocytes serve as Shiga toxin carriers during the development of hemolytic uremic syndrome. Cellular & Molecular Biology Letters. 30(1). 13–13. 1 indexed citations
2.
Li, Qiu, Linfei Hu, Huijuan Wang, et al.. (2020). FATS regulates polyamine biosynthesis by promoting ODC degradation in an ERβ-dependent manner in non-small-cell lung cancer. Cell Death and Disease. 11(10). 839–839. 7 indexed citations
3.
Yang, Yanfang, Jing Zhao, Yiran Mao, et al.. (2020). UBR5 over-expression contributes to poor prognosis and tamoxifen resistance of ERa+ breast cancer by stabilizing β-catenin. Breast Cancer Research and Treatment. 184(3). 699–710. 17 indexed citations
4.
Gu, Yurong, Lubiao Chen, Yifan Lian, et al.. (2019). Serum HBV pregenomic RNA is correlated with Th1/Th2 immunity in treatment‐naïve chronic hepatitis B patients. Journal of Medical Virology. 92(3). 317–328. 15 indexed citations
5.
Huang, Yubei, Zhongsheng Tong, Kexin Chen, et al.. (2019). Interpretation of breast cancer screening guideline for Chinese women. Cancer Biology and Medicine. 16(4). 825–835. 30 indexed citations
6.
Li, Xiaoyan, Liang Zhou, Yurong Gu, et al.. (2019). Quantative HBsAg level correlates dendritic cells maturation in chronic hepatitis B patients. Clinics and Research in Hepatology and Gastroenterology. 44(3). 321–328. 4 indexed citations
7.
Guo, Yan, Lína Zhang, & Lin Gu. (2018). Feasibility of neoadjuvant chemotherapy combined with breast conserving surgery for breast cancer. Tumori. 38(3). 242–249. 1 indexed citations
8.
Yang, Yanfang, Zhansheng Jiang, Lili Chang, et al.. (2017). Expression of STIM1 is associated with tumor aggressiveness and poor prognosis in breast cancer. Pathology - Research and Practice. 213(9). 1043–1047. 25 indexed citations
9.
Zhang, Yanqi, et al.. (2015). [Clinicopathological features and prognostic factors of 22 cases of primary squamous cell carcinoma of the breast].. PubMed. 37(4). 293–6. 1 indexed citations
10.
Wang, Rongrong, et al.. (2014). BAG-1, EGFR, and PARP-1 expressions in breast cancer and their clinical significance. Clinical Oncology and Cancer Research. 41(13). 866–871. 1 indexed citations
11.
Gu, Lin, et al.. (2014). Entecavir combined with furin inhibitor simultaneously reduces hepatitis B virus replication and e antigen secretion. Virology Journal. 11(1). 165–165. 11 indexed citations
13.
Shi, Xiaoyan, Lin Gu, Jie Chen, Xirong Guo, & Yingli Shi. (2013). Downregulation of miR-183 inhibits apoptosis and enhances the invasive potential of endometrial stromal cells in endometriosis. International Journal of Molecular Medicine. 33(1). 59–67. 62 indexed citations
14.
15.
Yuan, Dongping, Lin Gu, Jun Long, et al.. (2013). Shikonin reduces endometriosis by inhibiting RANTES secretion and mononuclear macrophage chemotaxis. Experimental and Therapeutic Medicine. 7(3). 685–690. 13 indexed citations
16.
Yang, Yan, et al.. (2012). [Clinical features and prognosis of 25 cases of breast carcinosarcoma].. PubMed. 34(8). 620–3. 6 indexed citations
17.
Chen, Yan, et al.. (2012). Furin mRNA expression in peripheral blood correlates with chronic hepatitis B virus infection. Hepatology Research. 43(2). 208–216. 6 indexed citations
18.
Sun, Jingyan, Xu Xu, Juntian Liu, et al.. (2010). Epigenetic regulation of retinoic acid receptor β2 gene in the initiation of breast cancer. Medical Oncology. 28(4). 1311–1318. 9 indexed citations
20.
Gu, Lin, et al.. (2005). Simultaneous detection of two major lamivudine-resistant mutants using competitively differentiated-PCR. Journal of Virological Methods. 128(1-2). 168–175. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026